During the COVID-19 epidemic, the medical treatment, disease status, and medication status of patients with chronic airway disease have not been studied. The purpose of this study is to investigate the management and healthcare utilization of patients with chronic airway disease and the influencing factors during the COVID-19 epidemic.
During the COVID-19 epidemic, the medical treatment, disease status, and medication status of patients with chronic airway disease have not been studied. The purpose of this study is to investigate the management and healthcare utilization of patients with chronic airway disease and the relevant factors during the COVID-19 epidemic. Using cross-sectional research methods, telephone interviews and questionnaire surveys were used to investigate the management and healthcare utilization of patients with chronic airway disease （COPD and asthma）during the COVID-19 epidemic.
Study Type
OBSERVATIONAL
Enrollment
153
No intervention
Peking University Third Hospital
Beijing, Beijing Municipality, China
Respiratory symptoms
COPD Assessment Test (CAT)
Time frame: through study completion, an average of 2 week.
Frequency of exacerbation during the COVID-19 epidemic
Frequency of exacerbation during the COVID-19 epidemic
Time frame: through study completion, an average of 2 week.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.